Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology
Antibody-drug conjugates—an emerging class of cancer treatment | British Journal of Cancer
Antibody-drug conjugate - Wikipedia
PDF) Linkers Having a Crucial Role in Antibody–Drug Conjugates
Bioprocess development of antibody-drug conjugate production for cancer treatment
PDF) Site-Specific Antibody Conjugation for ADC and Beyond
Conjugation methods for ADC development. ADC production using... | Download Scientific Diagram
Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.,Analytical Chemistry - X-MOL
Antibody-Drug Conjugates: The New Frontier of Chemotherapy
Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody–Drug Conjugates | SpringerLink
Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery
On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency | Scientific Reports
Araris Biotech
Assessing ADC Plasma Stability by LC-MS Methods | SpringerLink
PDF) Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs)
Antibody–Drug Conjugates: Perspectives and Characterization | Chromatography Online
Antibody-Drug Conjugates: The New Frontier of Chemotherapy
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates | Scientific Reports
Antibody–drug conjugates | Nature Reviews Drug Discovery
Kadcycla ADC - Potency Regulatory and Bioprocessing Concerns of ADCs - BioProcess InternationalBioProcess International
Cleavable linkers in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C8CS00676H
PDF) Analytical methods for physicochemical characterization of antibody drug conjugates
